Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Eur J Pharmacol

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    August 2022
  1. SHEN S, Duan J, Hu J, Qi Y, et al
    Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction.
    Eur J Pharmacol. 2022;929:175126.
    PubMed     Abstract available


    July 2022
  2. NOGAWA H, Muraki Y, Kawai T, Kuninishi Y, et al
    Pharmacological characterisation of electrocardiogram J-Tpeak interval in conscious Guinea pigs.
    Eur J Pharmacol. 2022;927:175065.
    PubMed     Abstract available


  3. HAN Y, Xiong C, Zhang LZ, Wang YD, et al
    Antagonism of N/OFQ attenuates externalization of beta1-adrenergic receptor and ventricular arrhythmias in acute myocardial ischemia rat model.
    Eur J Pharmacol. 2022;929:175139.
    PubMed     Abstract available


    June 2022
  4. PONNIAN SMP
    Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- kappaB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats.
    Eur J Pharmacol. 2022;924:174909.
    PubMed     Abstract available


    January 2022
  5. BALLET V, Bohme GA, Brohan E, Boukaiba R, et al
    In vitro ion channel profile and ex vivo cardiac electrophysiology properties of the R(-) and S(+) enantiomers of hydroxychloroquine.
    Eur J Pharmacol. 2022;915:174670.
    PubMed     Abstract available


    December 2021
  6. THOMET U, Amuzescu B, Knott T, Mann SA, et al
    Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
    Eur J Pharmacol. 2021;913:174632.
    PubMed     Abstract available


  7. KILFOIL P, Feng SL, Bassyouni A, Lee T, et al
    Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters.
    Eur J Pharmacol. 2021;912:174584.
    PubMed     Abstract available


    November 2021
  8. FANG J, Kong B, Shuai W, Xiao Z, et al
    Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia.
    Eur J Pharmacol. 2021 Nov 5:174622. doi: 10.1016/j.ejphar.2021.174622.
    PubMed     Abstract available


  9. YANG HW, Lin CY, Lin FZ, Yu PL, et al
    Phosphodiesterase-1 inhibitor modulates Ca(2+) regulation in sirtuin 1-deficient mouse cardiomyocytes.
    Eur J Pharmacol. 2021;910:174498.
    PubMed     Abstract available


  10. JIE LJ, Li YD, Zhang HQ, Mao L, et al
    Mechanisms of gefitinib-induced QT prolongation.
    Eur J Pharmacol. 2021;910:174441.
    PubMed     Abstract available


    September 2021
  11. NAFFAA MM, Al-Ewaidat OA
    Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.
    Eur J Pharmacol. 2021;906:174278.
    PubMed     Abstract available


  12. GERGS U, Bruckner T, Hofmann B, Neumann J, et al
    The proarrhythmic effects of hypothermia in atria isolated from 5-HT4-receptor-overexpressing mice.
    Eur J Pharmacol. 2021;906:174206.
    PubMed     Abstract available


    August 2021
  13. BELEM-FILHO IJA, Brasil TFS, Fortaleza EAT, Antunes-Rodrigues J, et al
    A functional selective effect of oxytocin secreted under restraint stress in rats.
    Eur J Pharmacol. 2021;904:174182.
    PubMed     Abstract available


    June 2021
  14. BAI S, Wang X, Wu H, Chen T, et al
    Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.
    Eur J Pharmacol. 2021;901:174095.
    PubMed     Abstract available


    May 2021
  15. SAPONARA S, Fusi F, Iovinelli D, Ahmed A, et al
    Flavonoids and hERG channels: Friends or foes?
    Eur J Pharmacol. 2021;899:174030.
    PubMed     Abstract available


    April 2021
  16. SILVA EAP, Carvalho JS, Dos Santos DM, Oliveira AMS, et al
    Cardiovascular effects of farnesol and its beta-cyclodextrin complex in normotensive and hypertensive rats.
    Eur J Pharmacol. 2021 Apr 2:174060. doi: 10.1016/j.ejphar.2021.174060.
    PubMed     Abstract available


    February 2021
  17. ZEQUN Z, Yujia W, Dingding Q, Jiangfang L, et al
    Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    Eur J Pharmacol. 2021;893:173813.
    PubMed     Abstract available


    December 2020
  18. AMSTETTER D, Badt F, Rubi L, Bittner RE, et al
    The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo.
    Eur J Pharmacol. 2020 Dec 17:173818. doi: 10.1016/j.ejphar.2020.173818.
    PubMed     Abstract available


    September 2020
  19. FO Y, Zhang C, Chen X, Liu X, et al
    Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats.
    Eur J Pharmacol. 2020 Sep 30:173614. doi: 10.1016/j.ejphar.2020.173614.
    PubMed     Abstract available


    July 2020
  20. KOJIMA A, Fukushima Y, Itoh H, Imoto K, et al
    A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane.
    Eur J Pharmacol. 2020 Jul 22:173378. doi: 10.1016/j.ejphar.2020.173378.
    PubMed     Abstract available


    June 2020
  21. ABDULSALAM TM, Hasanin AH, Mohamed RH, El Sayed Badawy A, et al
    Angiotensin receptor-neprilysin inhibitior)thiorphan/irbesartan( decreased ischemic-reperfusion induced ventricular arrhythmias in rat; in vivo study.
    Eur J Pharmacol. 2020 Jun 25:173295. doi: 10.1016/j.ejphar.2020.173295.
    PubMed     Abstract available


    April 2020
  22. RAHM AK, Muller ME, Gramlich D, Lugenbiel P, et al
    Inhibition of cardiac Kv4.3 (Ito) channel isoforms by class I antiarrhythmic drugs lidocaine and mexiletine.
    Eur J Pharmacol. 2020 Apr 29:173159. doi: 10.1016/j.ejphar.2020.173159.
    PubMed     Abstract available


  23. LI LY, Lou Q, Liu GZ, Lv JC, et al
    Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation.
    Eur J Pharmacol. 2020 Apr 20:173120. doi: 10.1016/j.ejphar.2020.173120.
    PubMed     Abstract available


    March 2020
  24. LI Q, Zhai Z, Li J
    Fibroblast growth factor homologous factors are potential ion channel modifiers associated with cardiac arrhythmias.
    Eur J Pharmacol. 2020;871:172920.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: